Evidence map›Paper›PMID 27279839›Full record

ArticleArchives of medical science : AMS2016

Recombinant human bone morphogenetic protein-2 suspended in fibrin glue enhances bone formation during distraction osteogenesis in rabbits.

Yunfeng Li, Rui Li, Jing Hu, Donghui Song, Xiaowen Jiang, Songsong Zhu

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Effects ofBioscience reports · 2017
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yunfeng LiThe State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, Sichuan University West China Hospital of Stomatology, Chengdu, China.
Rui LiDepartment of Stomatology, The General Hospital of People's Liberation Army, Beijing, China.
Jing HuThe State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, Sichuan University West China Hospital of Stomatology, Chengdu, China.
Donghui SongThe State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, Sichuan University West China Hospital of Stomatology, Chengdu, China.
Xiaowen JiangThe State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, Sichuan University West China Hospital of Stomatology, Chengdu, China.
Songsong ZhuThe State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, Sichuan University West China Hospital of Stomatology, Chengdu, China.
Sichuan University · CNState Key Laboratory of Oral DiseasesPeople's Liberation Army No. 150 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBone morphogenetic protein-2 (BMP-2) has high potential for bone formation, but its in vivo effects are unpredictable due to the short life time. This study was designed to evaluate the effects of recombinant human (rh) BMP-2 suspended in fibrin on bone formation during distraction osteogenesis (DO) in rabbits. MATERIAL AND

methodsThe in vitro release kinetics of rhBMP-2 suspended in fibrin was tested using an enzyme-linked immunosorbent assay. Unilateral tibial lengthening for 10 mm was achieved in 48 rabbits. At the completion of osteodistraction, vehicle, fibrin, rhBMP-2 or rhBMP-2 suspended in fibrin (rhBMP-2 + fibrin) was injected into the center of the lengthened gap, with 12 animals in each group. Eight weeks later, the distracted callus was examined by histology, micro-CT and biomechanical testing. Radiographs of the distracted tibiae were taken at both 4 and 8 weeks after drug treatment.

resultsIt was found that fibrin prolonged the life span of rhBMP-2 in vitro with sustained release during 17 days. The rhBMP-2 + fibrin treated animals showed the best results in bone mineral density, bone volume fraction, cortical bone thickness by micro-CT evaluation and mechanical properties by the three-point bending test when compared to the other groups (p < 0.05). In histological images, rhBMP-2 + fibrin treatment showed increased callus formation and better gap bridging compared to the other groups.

conclusionsThe results of this study suggest that fibrin holds promise to be a good carrier of rhBMP-2, and rhBMP-2 suspended in fibrin showed a stronger promoting effect on bone formation during DO in rabbits.

Indexed as

bone formationbone morphogenic protein-2distraction osteogenesisfibrinrelease kinetics

Identifiers

PMID27279839
PMCPMC4889683
OpenAlexW2405648614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.